TheEdgeResearch
Home / Stocks / VCYT

Veracyte, Inc. (VCYT)

NASDAQ Healthcare Medical - Diagnostics & Research
$60.49 ▲ +3.31%
Market Cap
$4.83B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.98
52-Wk Range
22.61-60.83
CEO
Marc Stapley
Country
US
Currency
USD

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc…

Open full interactive analysis & DCF →